Introduction. The objective of our study was to evaluate the performance of detailed fetal echocardiography by skilled obstetric physician sonologists in the diagnosis of congenital heart disease (CHD) in a Chinese population. Material and methods. This investigation included a multicenter prospective cohort of 10 259 pregnant women attending 10 regional tertiary hospitals in China. The inclusion criteria were singleton pregnancy and gestational age from 18 to ≤28 weeks. Women with multiple pregnancies were excluded. A detailed fetal echocardiography was performed by trained physicians with at least 3 years of experience. The primary outcome measures included sensitivity, specificity, and positive and negative likelihood ratios of detailed fetal echocardiography in prenatal detection of CHD. Results. The sensitivity and specificity of fetal echocardiography in detecting any CHD were 33.9 and 99.8%, respectively, in the low-risk population, and 68.8 and 99.4%, respectively, in the high-risk population. For detecting major CHDs, fetal echocardiography had a high sensitivity and specificity, and satisfactory positive and negative likelihood ratios in both the low-risk population (88.2, 100%, 6947.7, and 0.118, respectively) and high-risk population (100, 99.9%, 833.3, and <0.0001, respectively). The sensitivity and likelihood ratios were substantially lower for detecting minor CHDs in both populations. Conclusions. Detailed fetal echocardiography performed by skilled physicians had high detection rate for major CHD in both low-risk and high-risk populations. However, its value for detecting minor CHD was limited. The incorporation of fetal echocardiography with multiple cardiac views into routine ultrasound screening may improve the detection rate of fetal major CHD and facilitate appropriate parental counseling.
Introduction
Congenital heart disease (CHD) is the most common birth defect worldwide. In China, there are approximately 16 000 000 newborns, along with 130 000 new cases of CHD, every year (8.1&) (1) . CHD has been the most
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Detailed fetal echocardiography performed by skilled physicians had high detection rates for major congenital heart disease. The incorporation of fetal echocardiography with multiple cardiac views into routine ultrasound screening may improve detection of major congenital heart disease. prevalent perinatal congenital anomaly for approximately 10 years (1) , and it remains a primary congenital cause of mortality in children under 5 years (2) .
Prenatal diagnosis of CHD plays a substantial role in improving the outcome of fetal CHD (3) by providing parents with useful information and contributing to optimized perinatal management. Since the 1980s, fetal echocardiography examination has become the most important technique in the prenatal detection of CHD (4) . Fetal ultrasound screening, including the "basic" and "extended basic" cardiac views, has significantly improved the prenatal detection of CHD (5, 6) . However, the reported detection rates were not high, 25~65.5% for any CHD (5, 7, 8) , and 49-77% for major CHD (8) (9) (10) (11) . A considerable proportion of fetuses with major CHD are not diagnosed prenatally.
In China, although nuchal translucency screening and first-trimester fetal echocardiography have recently become available in some regional tertiary (highest-level in China) obstetric centers, the technique of fetal echocardiography in the second trimester has been explored since the late 1980s. In China, ultrasound screening examinations for fetal anomalies are typically conducted in regional tertiary obstetric centers and secondary obstetric hospitals and are performed by physicians experienced in obstetric ultrasonography rather than sonographers, which is the common practice in many other countries. Pregnant women suspected of having fetal cardiac abnormalities on ultrasound screening and those with other indications are recommended to have detailed fetal echocardiography, which is typically available in regional tertiary obstetric centers and some secondary obstetric hospitals.
The objective of this study was to evaluate the performance of detailed fetal echocardiography performed by skilled physicians trained in obstetric ultrasonography in the prenatal diagnosis of CHD.
Material and methods
A multicenter prospective cohort study was conducted in 10 regional tertiary obstetrics or children's hospitals from eight provinces in China between 2009 Pregnant women with singleton pregnancies attending obstetric hospitals for routine ultrasound screening were recruited for our cohort. They were divided into low-risk and high-risk groups. The low-risk women were randomly recruited from all the pregnant women registered in the obstetric hospitals between 18 and 24 gestational weeks. The high-risk group consisted of pregnant women between 18 and ≤28 gestational weeks who were referred for fetal echocardiography and deemed to be at increased risk of having a fetus with CHD. The indications for referral included:
1. Fetal factors: fetal extracardiac abnormalities, unsatisfactory fetal heart imaging or suspected fetal cardiac abnormality on ultrasound screening, fetal arrhythmia, and increased nuchal translucency in the first-trimester screening. 2. Maternal factors: maternal CHD, advanced maternal age (>35 years), maternal metabolic diseases, history of maternal viral infection in early pregnancy, and maternal exposure to teratogens. 3. Family and obstetric history: paternal CHD, parental family history of CHD, previous child/fetus with cardiac or extracardiac malformation, and genetic disorders that increase the risk of CHD.
All women who consented to participate in the study had detailed fetal echocardiography in the second trimester of pregnancy (18 to ≤28 weeks). All examinations were performed at tertiary centers by physicians skilled in obstetric ultrasound using high-quality obstetric ultrasound systems with 2-7 MHz transducers. Twenty physicians (eight in the low-risk group and 12 in the high-risk group) were involved. All the physicians had at least 3 years of experience in fetal cardiac ultrasound scanning, and there were no differences in the individual detection rates between the two groups. Furthermore, they received uniform training before the start of the study and were regularly assessed during the study period. A common protocol based on the international fetal echocardiography guidelines (6, 12) was used during the study period. The examination included two-dimensional views, including cross-sectional view of the fetal abdomen, four-chamber view of the heart, ventricular outflow tract view, and three vessels and trachea view; long axis of the duct and aortic arch view and inferior and superior vena cava view when appropriate; the sizes of cardiac chambers and great arteries; color-flow mapping and pulsed-wave Doppler interrogation of blood flow through the cardiac valves and great vessels; cardiac axis angles; and M-mode measurements. The mean duration of the examination of each fetus with a normal heart was less than 30 min. In addition, the extracardiac abnormalities of the fetuses detected via ultrasound screening were recorded.
When a fetus was prenatally diagnosed with a CHD, the parents were informed about the condition and provided with medical counseling by a multidisciplinary team in each center. The team included the obstetricians, physician sonologist, and in some cases, a pediatric cardiologist or cardiac surgeon. Management options were discussed.
Karyotyping was performed in a small subgroup of the fetuses. In China, no unified legislation exists for the termination of pregnancies. In most provinces and areas, it is allowed up to 28 gestational weeks. When the parents chose the termination of pregnancy, an autopsy was performed to verify the final diagnosis if the parents provided consent. The autopsies were performed soon after the abortion by pathologists in the same hospital and were confirmed by both pathologists and physician sonologists. The pathologists involved were experienced in fetal autopsy, and some of them had been trained in pediatric cardiology. When the pregnancy was continued, the fetuses were followed until after birth. A postnatal echocardiography was performed by pediatric cardiologist from the same hospital or children's hospitals in the same region, and a final diagnosis was subsequently made. The prenatal and final diagnoses were compared, and the performance of fetal echocardiography was evaluated.
For better evaluation, the CHD cases were divided into major and minor CHDs according to the severity of fetal cardiac malformations. Cardiac defects with severe clinical manifestations (for example heart failure or cyanosis) and/ or those requiring medical or surgical intervention in utero or within the first year after birth were considered major CHDs. These cases included single atrium, single ventricle, atrioventricular septal defects, abnormal connection of great arteries, severe aortic stenosis, coarctation of aorta, hypoplastic aortic arch, cardiosplenic syndrome, and combined complex malformations. The CHDs with mild manifestations that only required follow up without intervention in infancy were considered to be minor. These included isolated ventricular septal defects (VSD) and atrial septal defects, noncritical pulmonary valve stenosis (PVS), and mild aortic stenosis. In our study, isolated interatrial shunt (including secundum atrial septal defects and patent foramen ovale), patent ductus arteriosus, isolated persistent left superior vena cava, and isolated rightsided aortic arch were not included in the CHD cases.
Results
A total of 10 259 pregnant women (5995 in the low-risk group and 4264 in the high-risk group) participated in this study. The descriptive characteristics of the high-risk and low-risk populations are presented in Table 1 .
The flow of participants is presented in Figure 1 . Follow-up data were available for 6485 fetuses who were included in the final statistical analysis, including 3950 in the low-risk group and 2535 in the high-risk group. Twenty-eight fetuses were prenatally diagnosed with CHDs (major 15 and minor 13) in the low-risk group, the prevalence of prenatally diagnosed CHDs was 7.1& (major CHDs 3.79& and minor CHDs 3.29&), and 60 (23.7&) fetuses were prenatally diagnosed with CHDs in the high-risk group. Finally, 59 fetuses (major CHD 17 and minor CHD 42) in the low-risk group and 64 fetuses (major CHD 33 and minor CHD 31) in the high-risk group were postnatally confirmed to have a CHD. The prevalences of finally confirmed CHDs in the two groups were 14.9 and 25.2&, respectively. Among these fetuses, prenatal diagnosis of CHDs was made in 20 fetuses in the low-risk group and 44 fetuses in the high-risk group. The overall sensitivity and specificity of fetal echocardiography in the prenatal detection of CHDs were 52.0 and 99.6%, respectively, in the total study population, 33.9 and 99.8%, respectively, in the low-risk population, and 68.8 and 99.4%, respectively, in the high-risk population.
The types of finally diagnosed CHDs are presented in Table 2 . Among the major CHD cases, 15 of 17 cases in the low-risk group had been correctly diagnosed prenatally at an average gestational age of 22.6 AE 1.5 weeks. One case of coarctation of the aorta and one case of aortic arch hypoplasia in this group were not prenatally detected. In the high-risk group, all 33 cases were prenatally diagnosed at an average gestational age of 24.2 AE 3.4 weeks. The diagnostic performance of detailed fetal echocardiography is presented in Table 3 . The sensitivity for aortic arch abnormalities (coarctation of aorta and hypoplastic or interrupted aortic arch) was 80%, which was the lowest among the major CHD types in this study. In the low-risk group, the sensitivity for the detection of aortic arch abnormalities was only 33.3%. The average gestational ages at the time of examination were comparable between the prenatally diagnosed cases and the missed cases (23.2 AE 3.6 vs. 23.2 AE 0.0 weeks, respectively, p > 0.05). Among the minor CHD cases, only five of 42 cases in the low-risk group and 11 of 31 cases in the high-risk group were correctly diagnosed prenatally at an average gestational age of 22.3 AE 0.6 and 23.5 AE 3.3 weeks, respectively. The prenatally diagnosed CHD types included 10 perimembranous VSD, one muscular VSD, three PVS, one mesocardia and one dextrocardia. Fortynine cases of VSD (37 muscular VSD and 12 perimembranous VSD), seven cases of PVS and one case of mild tricuspid valve cleft were not prenatally diagnosed. The average sizes of the muscular VSD and perimembranous VSD diagnosed by postnatal echocardiography were 3.7 AE 0.8 and 4.2 AE 1.5 mm, respectively.
False-positive diagnoses of minor CHDs were made by fetal echocardiography. In the low-risk group, six fetuses diagnosed with perimembranous VSD and two fetuses suspected with mild PVS on fetal echocardiography were finally confirmed to be normal postnatally. In the high-risk group, nine perimembranous VSD, one muscular VSD, and three mild PVS that were suspected prenatally were not confirmed by postnatal examination. The diagnostic performance of fetal echocardiography for minor CHDs is also presented in Table 3 . Of all the minor CHD types, the sensitivity for perimembranous VSD was the highest (45.5%), followed by PVS (30%). The prenatal detection rate for muscular VSD was extremely poor (2.6%).
Among all the participants, the pregnancy termination rate as a result of a CHD diagnosis was 56.8% (50/88), with rates of 86.3% (44/51) for major CHDs and 16.2% (6/37) for minor CHDs. The autopsy reports were consistent with the prenatally made cardiac diagnoses.
In the low-risk group, 12 of 15 (80%) fetuses with prenatally diagnosed major CHDs were terminated (six fetuses had associated extracardiac abnormalities and were all terminated), compared with no fetus with minor CHDs (0/13). In the high-risk group, the termination rate of pregnancy among the fetuses with major CHDs was 88.9% (32/36) (eight fetuses had associated extracardiac malformations and were all terminated). The rate among fetuses with minor CHDs was 25% (6/24) (four fetuses had associated extracardiac malformations and, in another case, the mother had a history of infection and antibiotic use during early pregnancy) (see Table 4 ).
Discussion
This multicenter study demonstrated that detailed fetal echocardiography performed by skilled physician sonologists has high detection rates for major CHDs in both low-risk and high-risk populations. China has a situation where ultrasound screening is performed by physicians trained in obstetric ultrasonography rather than by technician sonographers. Therefore, it may be possible to train these physicians, who have substantial knowledge of fetal cardiovascular anatomy and physiology, and integrate detailed fetal echocardiography in routine secondtrimester screening. One major limitation of our study is that despite recruiting and performing detailed fetal echocardiography in 10 259 pregnancies, complete follow-up data were only available for 6485 fetuses/babies. Nevertheless, to our knowledge, this investigation is the largest multicenter study on detailed fetal echocardiography performed in China. The number of participants in our study is comparable with the study by Wang and Zhu, which was a single-center study conducted at a hospital in Hunan Province (13) . In our study, all the examinations were performed by skilled physicians trained in obstetric ultrasound and working in tertiary hospitals. A standardized protocol was used to perform fetal echocardiography, which included two-dimensional imaging, color flow mapping and pulsed-wave Doppler. All 6485 fetuses that were included in the data analysis had a final diagnosis of CHD confirmed or refuted by postnatal echocardiography (regardless of whether the babies had clinical symptoms or cardiac murmurs) or autopsy. This approach contributes to a more accurate evaluation of fetal echocardiography.
In our study, the prevalence of prenatally diagnosed CHDs in the low-risk group was 7.1&, including 3.79& for major CHDs and 3.29& for minor CHDs. The prevalence was slightly higher than in Romosan et al.'s report (2.2 and 2.9%, respectively) (14) , who investigated prenatal cardiac screening, not detailed fetal echocardiography. In another study from Spain, the prevalence of prenatally screened major CHDs (including large VSD) was 4.1& (10) . In our study, the prevalence of finally diagnosed CHDs in the low-risk group was substantially higher than the prenatally diagnosed CHDs (14.9& vs. 7.1&, respectively), and was also higher than the well-established prevalence of CHD in live births worldwide (approximately 6-12&). It is mainly because some pregnancies considered normal prenatally were diagnosed as involving a minor CHD after birth, and moreover, the finally diagnosed CHD cases included the fetuses who did not live until delivery because of selective termination of pregnancies. Therefore, 14.9& actually represented the prevalence of fetal CHDs in the low-risk population in our study. In this study, detailed fetal echocardiography exhibited high sensitivity and specificity and satisfactory positive and negative likelihood ratios for the detection of major CHDs in both the high-risk and low-risk populations. For minor CHDs, the specificity and positive likelihood ratio were acceptable; however, the sensitivity and negative likelihood ratio were unsatisfactory, particularly in the low-risk population. However, a high exclusion rate as a result of a lack of follow ups may have an impact on the results, and these findings should be interpreted with caution.
Consistent with previous reports (15-17), we detected a substantial proportion of CHDs (particularly major CHDs) in the low-risk population. The sensitivity in the low-risk and high-risk populations reached 88.2 and 100%, respectively, and the specificities were approximately 100% for both groups. This indicates that most fetuses with major CHDs were detected prenatally. It is also noteworthy that there were few false-positive cases of major CHDs. Stumpflen et al. (16) used routine detailed fetal echocardiography in 3085 unselected consecutive women and reported a sensitivity and specificity of 85.5 and 100%, respectively, for the detection of any CHD. Similarly, in Ozbarlas's study (18) that included 3782 high-risk and low-risk women, the sensitivity and specificity of fetal echocardiography for detecting major CHDs were 86 and 99%, respectively. These results are consistent with our findings. Compared with detailed fetal echocardiography, the detection rate of prenatal ultrasound screening, which includes only the "basic" and "extended basic" cardiac views, appears to be lower (50-77%) in low-risk population (8) (9) (10) (11) .
Due to the unsatisfactory performance of obstetric screening for fetal CHD, some researchers have advocated for routine fetal echocardiography in pregnancy. In the USA, ultrasound screening incorporating multiple cardiac views for fetal cardiac malformations has become the mainstay (19) . In China, ultrasound screening examinations are performed by physicians experienced in obstetric ultrasonography rather than sonographers, and are typically conducted in regional tertiary obstetric centers and secondary obstetric hospitals. Moreover, as indicated by the American Heart Association, detection rates may improve with uniform standards for training and performance (19) . Our study, which used a uniformed standardized protocol, also demonstrated satisfactory performance. Therefore, if fetal echocardiography is incorporated into routine ultrasound screening, and physician sonologists are trained with uniform standards, the prenatal diagnosis of CHD may be more effective in China. However, because of the substantial population in China, the feasibility and cost-effectiveness of detailed fetal echocardiography appear to be a matter of debate. The incorporation of multiple cardiac views into the ultrasound screening could be the first step.
Compared with the low-risk group, the sensitivity of fetal echocardiography in the high-risk group was slightly higher. This finding suggests that in fetuses with risk factors, such as suspected cardiac abnormalities on routine prenatal screening, there is a high possibility of CHD detection. For fetuses with known risk factors, the examiners may have a tendency to be more careful and meticulous, which may also contribute to the improved sensitivity. In Ott's (20) study, fetal cardiac screening that included the four-chamber and left ventricular outflow tract views had a substantially higher sensitivity in the high-risk group than the low-risk group. Our study that used more detailed fetal echocardiography provided similar results.
The transverse aortic arch view (three vessels and trachea view) and long axis of aortic arch view were included in the evaluation protocol; however, the detection rate of aortic arch abnormalities was lowest among all major CHD types, particularly in the low-risk population. Forbus et al. (21) and Gottliebson et al. (22) have indicated that the diagnosis of aortic arch by fetal echocardiography remains challenging. The examiner's experience, quality of the ultrasound system, maternal body composition, fetal position, and the natural evolution of CHD may influence the detection rate. Nevertheless, the inclusion of the transverse and long axis of aortic arch views in fetal echocardiography may improve the detection rate of this CHD type to some extent. In the updated ISUOG practice guidelines in 2013, the three vessels and trachea view has been included in the sonographic screening examination of fetal heart to enable the detection of aortic arch abnormalities (23) .
In our study, detailed fetal echocardiography had a sensitivity of 52.0% for detecting any CHD in the total population included in the study, which was significantly lower than the previous reports from other countries (83-100%) (16, 17, 22) . The detection rates for any CHD, respectively, in the two groups were also lower than the data recently summarized by Zhang et al. (24) . This may be a result of the very low detection rate of minor CHD, particularly in the low-risk group (11.9%). Among all minor CHD types, muscular VSD was predominantly detected after birth but mostly missed prenatally in both groups. Previous studies have reported similar findings. In Gottliebson et al.'s study (22) , muscular VSD was the most frequently missed type by fetal echocardiography. Tegnander et al. (9) summarized the routine fetal cardiac screening in unselected fetuses and determined that all the muscular VSDs had been missed and accounted for most of the minor CHD types not prenatally detected. Our findings demonstrate that detailed fetal echocardiography has no advantage compared with cardiac screening examination for detecting this type of CHD. As a substantial proportion of babies with muscular VSD may have no clinical manifestations including clear cardiac murmur, some babies may never be diagnosed, and their small defects close spontaneously with age. However, in our study, all babies were examined by neonatal echocardiography, regardless of whether they had clinical manifestations. We speculate that this approach improves the number of postnatally detected cases and decreases the sensitivity of prenatal diagnosis. Our findings also indicate that the incidence of muscular VSD among live births may have been underestimated in previous reports.
Compared with muscular VSD, perimembranous VSD and PVS had higher sensitivities, but remained substantially lower than major CHDs. Moreover, some prenatally diagnosed cases of VSDs and mild PVS were ultimately determined to be normal after birth. In previous studies of fetal cardiac screening (8, 9, 14) , the detection rates of minor CHD, which mainly referred to isolated septal defects and mild pulmonary/aortic stenosis, were much lower than major CHD. The intrauterine evolution of cardiac malformations may be one of the causes for the low detection rates. Some septal defects or valve stenoses may be too small or mild to be detected at examination in the second trimester. However, they continue to progress and are detected after birth. Some septal defects may spontaneously close in utero and appear normal after birth (25) .
In our study, the parents of 56.8% of the fetuses opted for termination of pregnancy following a diagnosis of CHD. The termination rates were clearly high for fetal major CHDs (86.3%) in both the low-risk and high-risk groups and were much lower for minor CHDs (16.2%). The severity of CHD had a substantial effect on the parents' decisions regarding termination or continuation of pregnancy. Compared with the data from other countries, 20-59% for total major CHDs (3, 26, 27) and higher rates for special types (28) (29) (30) (31) , the rates in our study were higher. It is worth noting that the termination rates were very high in fetuses with associated extracardiac abnormalities regardless of major or minor CHDs, which was consistent with a previous report (29) . The associated extracardiac abnormalities may influence the parents' decisions, even though their fetuses were diagnosed with only a minor CHD. Furthermore, birth policy in China may also have an influence on parental decisions.
Conclusion
In this multicenter study in China, detailed fetal echocardiography performed by skilled physicians demonstrated high detection rates for major CHDs in both high-risk and low-risk populations. However, its value for the detection of minor CHDs was limited. Most Chinese parents chose to terminate the pregnancy when the fetus was prenatally diagnosed with a major CHD with or without extracardiac abnormalities. The incorporation of fetal echocardiography with multiple cardiac views into routine ultrasound screening and training ultrasonographic physicians with a uniform standard may improve the detection rate of fetal major CHDs, which would provide parents with more information and facilitate appropriate prenatal counseling and decision-making.
